Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
JNJ-40411813 REF: IN-DA008TH4CAS: 1127498-03-6 | % | 127.00 €~630.00 € | Tue 07 Jan 25 | |
JNJ-40411813 REF: TM-TQ0094CAS: 1127498-03-6 | 99.74% | 54.00 €~724.00 € | Tue 14 Jan 25 | |
ADX 71149 REF: 3D-CVB49803CAS: 1127498-03-6 | Min. 95% | - - - | Discontinued product |
JNJ-40411813
CAS:1127498-03-6
Formula:
C20H25ClN2O
Purity:
%
Color and Shape:
Solid
Molecular weight:
344.8783
Ref: IN-DA008TH4
10mg | 127.00 € | ||
25mg | 181.00 € | ||
50mg | 162.00 € | ||
100mg | 273.00 € | ||
250mg | 614.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
JNJ-40411813
CAS:1127498-03-6
JNJ-40411813 (ADX-71149) (ADX-71149) is a new positive allosteric modulator of the metabotropic glutamate 2 receptor …
Formula:
C20H25ClN2O
Purity:
99.74%
Color and Shape:
Solid
Molecular weight:
344.88
Ref: TM-TQ0094
1mg | 54.00 € | ||
5mg | 114.00 € | ||
10mg | 179.00 € | ||
25mg | 299.00 € | ||
50mg | 426.00 € | ||
100mg | 547.00 € | ||
200mg | 724.00 € | ||
1mL*10mM (DMSO) | 128.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
ADX 71149
CAS:1127498-03-6
ADX 71149 is a drug that is being developed by Addex Therapeutics as a treatment …
Formula:
C20H25ClN2O
Purity:
Min. 95%
Molecular weight:
344.88 g/mol
Ref: 3D-CVB49803
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
500mg | Discontinued | Request information |